PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 22 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Gleditsia saponin C demonstrated inhibitory effects against HIV replication in H-9 cells with an EC50 of 1.1 microM [PMID:7494144]
Galactomannan (EGSP) from G. japonica var. delavayi showed potent concentration-dependent scavenging activity against DPPH, ABTS, and OH radicals in vitro [PMID:41544791]
Gleditsia japonica is identified as a potential source of natural free radical scavengers [PMID:18505484]
Evidence summary
PubMed sources
- 1.PMID: 17396946 (1982) — Gleditsia saponins. · Planta medica
- 2.PMID: 38383559 (2024) — Characterization of the chloroplast genome of Gleditsia species and comparative analysis. · Scientific reports
- 3.PMID: 26643065 (2016) — Gleditsia species: An ethnomedical, phytochemical and pharmacological review. · Journal of ethnopharmacology
- 4.PMID: 42292535 (2026) — Chloroplast Genome Insights of Gleditsia japonica var. velutina and Evolutionary Implications for Variation and Phylogeny in Gleditsia. · Ecology and evolution
- 5.PMID: 28813687 (2017) — Prenylated purine alkaloids from seeds of Gleditsia japonica. · Phytochemistry